- Home
- SLRC vs AMLX Comparison
SLRC vs AMLX Comparison
Compare SLRC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRC
- AMLX
- Stock Information
- Founded
- SLRC 2007
- AMLX 2014
- Country
- SLRC United States
- AMLX United States
- Employees
- SLRC N/A
- AMLX N/A
- Industry
- SLRC Finance/Investors Services
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- SLRC Finance
- AMLX Health Care
- Exchange
- SLRC Nasdaq
- AMLX Nasdaq
- Market Cap
- SLRC 889.2M
- AMLX 749.9M
- IPO Year
- SLRC 2010
- AMLX 2022
- Fundamental
- Price
- SLRC $16.43
- AMLX $9.30
- Analyst Decision
- SLRC Hold
- AMLX Strong Buy
- Analyst Count
- SLRC 6
- AMLX 7
- Target Price
- SLRC $16.13
- AMLX $12.00
- AVG Volume (30 Days)
- SLRC 149.7K
- AMLX 991.1K
- Earning Date
- SLRC 08-05-2025
- AMLX 08-07-2025
- Dividend Yield
- SLRC 9.98%
- AMLX N/A
- EPS Growth
- SLRC N/A
- AMLX N/A
- EPS
- SLRC 1.63
- AMLX N/A
- Revenue
- SLRC $222,445,000.00
- AMLX N/A
- Revenue This Year
- SLRC N/A
- AMLX N/A
- Revenue Next Year
- SLRC $0.22
- AMLX N/A
- P/E Ratio
- SLRC $10.09
- AMLX N/A
- Revenue Growth
- SLRC N/A
- AMLX N/A
- 52 Week Low
- SLRC $13.64
- AMLX $2.05
- 52 Week High
- SLRC $17.94
- AMLX $9.36
- Technical
- Relative Strength Index (RSI)
- SLRC 52.85
- AMLX 69.71
- Support Level
- SLRC $16.26
- AMLX $7.63
- Resistance Level
- SLRC $16.62
- AMLX $8.47
- Average True Range (ATR)
- SLRC 0.22
- AMLX 0.44
- MACD
- SLRC 0.02
- AMLX 0.03
- Stochastic Oscillator
- SLRC 75.70
- AMLX 95.89
About SLRC SLR Investment Corp.
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.